Unfortunately, the current situation in the N.N. Blokhin Russian Cancer Research Center with possible numerous resignations of doctors is far from rare.

Russian doctors are not only professionals, but also highly erudite people. The vast majority of the respondents in an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social network for doctors consider it impossible to remove Latin from curriculum or reduce the hours in medical universities. In addition to half-joking reasons, such as “to swear in the presence of strangers” or “to learn Gaudeamus”, the doctors note the importance of “professional community”, “friend / foe criteria”, the need to “soften the diagnosis for relatives”, etc.

In early September, Pharmacy Chain 36.6 announced a new project involving medical offices in pharmacies. These offices will be equipped in accordance with the therapeutic activity license, so that customers will be able to receive qualified medical care. The RNC Pharma analyst company, together with the Doktor Na Rabote (Doctor at Work) social network for doctors, conducted on online survey to find out under what conditions a doctor can consider working in those medical offices.

Between January and August 2019, Russia produced 255.8 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 20.2% higher than that of the same period in 2018. In physical terms, the dynamics are +4.5%, with the production volume of 2.83 bln units. If calculated in minimum dosage units (MDU), the dynamics are +3.5%, with the production volume of 47 bln MDUs.

Between January and July 2019, Russia imported 37.7 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms (rubles) 0.1% lower than that of the same period in 2018. The negative dynamics are only due to the import of feed supplements dropping by 12.4%. However, the import of feed supplements is the leader in the volume of import in monetary terms with 19.2 bln RUB. The dynamics in physical terms (units) are only negative, -2.4%.

Between January and July 2019, Russia imported 69.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 26.5% higher than that of the same period in 2018. As earlier, a significant price increase contributed to the high dynamics. In physical terms (tons), the dynamics are +4.5%, with the import volume of 7 thousand tons.

In July 2019, Russia imported 61.5 bln RUB worth of ready-made pharmaceuticals (free circulation prices, VAT included), which is in monetary terms (rubles) +31.5% higher than that of July 2018 and the highest volume since August 2010. Higher dynamics were witnessed in June 2016. However, the dynamics in physical terms are only +7.3%, with the import volume of 183.3 bln units.

In anticipation of the direct line with the Minister of Health of Russia Veronika Skvortsova, scheduled for September 13, 2019, the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social network for doctors conducted an online survey to find out which problems the professional community finds most concerning and which should be addressed to the Minister.

It is unlikely that by the end of this year the pharmaceutical wholesale will have seen any significant achievements or failures. As of yet, the market is only developing in terms of public procurement. The public procurement segment has always been a very specific area, with a limited circle of players and its own rules, which are also very vaguely worded. For example, that massive breakdown in trading due to difficulties in setting the initial maximum price of the contract.

Between January and June 2019, Russia imported 319.8 thousand units, 8.2 bln RUB worth of pharmaceuticals for clinical trials (CT) (free circulation prices), which is in physical terms (units) 15.8% lower and in monetary terms (rubles) 1.4% lower than that of the same period in 2018. While the negative dynamics in physical terms have been registered at least thrice since 2013, the negative dynamics in monetary terms have been registered for the first time.